Dysregulated inflammatory responses play a pivotal role in the initiation, development, and
progression of tumors, as demonstrated by the association between ulcerative colitis and the …

Patients with ulcerative colitis (UC) are at a two-to three-fold increased risk of developing
colorectal cancer (CRC) than the general population based on population-based data. UC …

Ulcerative colitis (UC) has closely been associated with an increased risk of colorectal
cancer. However, the exact mechanisms underlying colitis-associated cancer (CAC) …

The SARS-CoV-2 virus has caused a worldwide COVID-19 pandemic. In less than a year
and a half, more than 200 million people have been infected and more than four million …

Abstract Anemoside B4 (B4) is a compound extracted from Pulsatilla chinensis (P.
chinensis). Pharmacological studies have proved that it has certain anti-inflammatory …

Inflammatory bowel diseases (IBDs) are characterized by a persistent low-grade
inflammation that leads to an increased risk of colorectal cancer (CRC) development …

A leaky gut has been observed in a number of autoimmune diseases including type 1
diabetes, multiple sclerosis, inflammatory bowel disease, and systemic lupus …

Colon cancer (CC) is the third common neoplasm worldwide, and it is still a big challenge for
exploring new effective medicine for treating CC. Natural product promoting human health …

Colorectal cancer (CRC) is one of the most lethal malignancies worldwide and CRC therapy
remains unsatisfactory. In recent decades, nitric oxide (NO)—a free-radical gas—plus its …

Curcumin, one of the active ingredients of Curcuma longa (Jianghuang), has been reported
to exert multiple bioactivities, including pro‑apoptotic and anti‑inflammatory activities. In …